Imeik Technology Development saw the highest growth of 199% in patent filings in February and 99% in grants in March in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Imeik Technology Development’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Imeik Technology Development has been focused on protecting inventions in China(CN) with four publications in Q1 2024
The China(CN) Patent Office dominates the patent filings and grants with nearly 67% filings and 100% grants. The China(CN), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where Imeik Technology Development is filings its patents. Among the top granted patent authorities, Imeik Technology Development has 100% of its grants in China(CN).
AbbVie could be the strongest competitor for Imeik Technology Development
Petrochemicals related patents lead Imeik Technology Development portfolio
Imeik Technology Development has highest number of patents in petrochemicals.
For comprehensive analysis of Imeik Technology Development's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
